Synonyms: | |
Status: | Approved (2015) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | L01XJ02 |
UNII: | 0RLU3VTK5M |
InChI Key | VZZJRYRQSPEMTK-CALCHBBNSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C26H26F3N3O3 |
Molecular Weight | 485.51 |
AlogP | 5.82 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 63.69 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 35.0 |
Primary Target | |
---|---|
SMO |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Frizzled family G protein-coupled receptor
Smoothened receptor (frizzled family GPCR)
|
- | - | - | 6 | - | |
Unclassified protein
|
- | 6 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Medulloblastoma | 2 | D008527 | ClinicalTrials |
Carcinoma, Basal Cell | 2 | D002280 | ClinicalTrials |
Leukemia | 2 | D007938 | ClinicalTrials |
Multiple Myeloma | 2 | D009101 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Carcinoma, Basal Cell | 2 | D002280 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Graft vs Host Disease | 1 | D006086 | ClinicalTrials |
Esophageal Neoplasms | 1 | D004938 | ClinicalTrials |
Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 956697-53-3 |
ChEBI | 90863 |
ChEMBL | CHEMBL2105737 |
DrugBank | DB09143 |
DrugCentral | 5008 |
FDA SRS | 0RLU3VTK5M |
Guide to Pharmacology | 8199 |
PubChem | 24775005 |
SureChEMBL | SCHEMBL554455 |
ZINC | ZINC000068202099 |